Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33 | $26 | $33 | $70 |
| - Cash | $18 | $18 | $20 | $27 |
| + Debt | $21 | $18 | $21 | $16 |
| Enterprise Value | $36 | $26 | $34 | $59 |
| Revenue | $38 | $40 | $42 | $36 |
| % Growth | -4.3% | -5.9% | 16.7% | – |
| Gross Profit | $31 | $33 | $33 | $27 |
| % Margin | 82.6% | 84.7% | 78.3% | 75.5% |
| EBITDA | $0 | $2 | $0 | -$1 |
| % Margin | 0.5% | 6.3% | 0.8% | -2.4% |
| Net Income | -$6 | -$6 | -$6 | -$4 |
| % Margin | -17.1% | -15.9% | -13.3% | -9.7% |
| EPS Diluted | -0.46 | -0.44 | -0.38 | -0.24 |
| % Growth | -4.5% | -15.8% | -58.3% | – |
| Operating Cash Flow | -$1 | $6 | $8 | $6 |
| Capital Expenditures | -$0 | -$0 | -$2 | -$0 |
| Free Cash Flow | -$1 | $6 | $6 | $6 |